New England Peptide, CIL Ink Manufacturing, Marketing Deal for Quantitative Proteomics | GenomeWeb

NEW YORK (GenomeWeb News) – New England Peptide and Cambridge Isotope Laboratories today announced they will jointly manufacture and market preloaded resins for synthesizing stable isotope standards for quantitative proteomics.

CIL will provide high purity stable isotope amino acids to NEP who will load the isotopologues onto peptide synthesis resin. It will then perform quality control on the resins and redistribute them to CIL. The firms will co-market and sell the preloaded resins to peptide synthesis labs worldwide.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: adzuki bean genome, spontaneous mutation patterns in E. coli, and more.

An op-ed in the New York Times discusses banking of fecal samples to restore the gut microbiome.

Rules and regulations governing genetic modifications of human embryos vary from country to country, Nature News says, but such work may take place despite restrictions. is eyeing an expansion into genomic risk assessments, the Verge reports.